← Back to Clinical Trials
Recruiting NCT06596265

NCT06596265 Community Park-Based Programs for Health Promotion: The Fit2Lead Prospective Cohort Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06596265
Status Recruiting
Phase
Sponsor Duke University
Condition Anxiety
Study Type OBSERVATIONAL
Enrollment 1,000 participants
Start Date 2016-02-17
Primary Completion 2028-06-17

Eligibility & Interventions

Sex All sexes
Min Age 12 Years
Max Age 17 Years
Study Type OBSERVATIONAL
Interventions
Fit2Lead Group 1-2

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 1,000 participants in total. It began in 2016-02-17 with a primary completion date of 2028-06-17.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The Fit2Lead prospective cohort study examines the effects of a park-based youth mental health and resilience afterschool program on youth participant mental health, resilience, physical fitness, and violence prevention outcomes. Duke will perform a secondary analysis of the data collected as part of the Fit2Lead prospective cohort study run by Miami-Dade County Parks and Recreation.

Eligibility Criteria

Inclusion Criteria: * All participants enrolled in the Miami-Dade Fit2Lead study will be included in this secondary analysis * Aged 12-17 years, residing in Miami-Dade County Exclusion Criteria: * Anyone not enrolled in the Miami-Dade Fit2Lead study will be excluded from this secondary analysis * Aged \<12 or \>17 years, not residing in Miami-Dade County, cannot read and speak in English

Contact & Investigator

Central Contact
Principal Investigator

Emily D'Agostino

PRINCIPAL INVESTIGATOR

Duke University

Frequently Asked Questions

Who can join the NCT06596265 clinical trial?

This trial is open to participants of all sexes, aged 12 Years or older, up to 17 Years, studying Anxiety. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06596265 currently recruiting?

Yes, NCT06596265 is actively recruiting participants. Contact the research team at Emily.M.D'Agostino@duke.edu for enrollment information.

Where is the NCT06596265 trial being conducted?

This trial is being conducted at Miami, United States.

Who is sponsoring the NCT06596265 clinical trial?

NCT06596265 is sponsored by Duke University. The principal investigator is Emily D'Agostino at Duke University. The trial plans to enroll 1,000 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology